MEZZION PHARMA
MEZZION PHARMA
Social Links:
Industry:
Biotechnology
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.mezzion.co.kr
Total Employee:
11+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Font Awesome Apache Mobile Non Scaleable Content
Similar Organizations
Fosun Pharma
Fosun Pharma is a pharmaceutical company.
Hyacinths Pharma
Hyacinths Pharma is a pharmaceutical company.
Official Site Inspections
http://www.mezzion.co.kr
- Host name: 210.180.118.88
- IP address: 210.180.118.88
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "Mezzion Pharma"
Mezzion
We strive to discover, develop and deliver new hope for people living with Fontan circulation. Highlighting the real-life experiences of people living with Fontan circulation. From dancing โฆSee details»
Mezzion
Mezzion's Pipeline. ๋ค์ํ ์ ์์ฆ์ ๋ํ ํจ๋ฅ๊ณผ ์ฐ์ํ ์์ ์ฑ์ ์ ์ฝ๋ฌผ์ง ์ ๋ฐ๋ํ ๊ฐ๋ฐ. VIEW MORESee details»
Mission & Vision โ Mezzion
We strive to discover, develop and deliver new hope for people living with Fontan circulation through our extensive experience in drug development, clinical trials and a strong conviction โฆSee details»
History โ Mezzion
Since our founding in South Korea in 2002, Mezzion, Co., Ltd has remained steadfast in our efforts as a rare disease company to develop new treatments for people with single ventricle โฆSee details»
About Us | ๋ฉ์ง์จ - Mezzion
Mezzion Pharma Co., Ltd ใ๋ฉ์ง์จ์ 2002๋ 9์ 25์ผ ์์ฝํ์ ์กฐ์ ๋ฐ ํ๋งค์ ์ ์ฃผ ์ฌ์ ๋ชฉ์ ์ผ๋ก ํ์ฌ ์ค๋ฆฝ๋ ๋ฒ์ธ์ผ๋ก์, ์ค๋ฆฝ ์ด๋๋ก ๊ธ๋ก๋ฒ ์ ์ฝ ๊ฐ๋ฐ์ ์ฃผ๋ ฅํ๊ณ ์์ต๋๋ค.See details»
Mezzion - LinkedIn
John Hariadi Chief Medical Officer and Senior Vice President of Global Regulatory Affairs at Mezzion PharmaceuticalsSee details»
History | ๋ฉ์ง์จ - Mezzion
๋ฏธ๊ตญ๋ฒ์ธ ์ค๋ฆฝ(๋ฒ์ธ๋ช : Mezzion International LLC, ํฌ์๋ฐฉ๋ฒ : 100% ์ง๋ถํฌ์, ์ฃผ์์ ํ : ํฐํํ์ ์น๋ฃ์ )See details»
Mezzion Raises $40 Million to Advance a First-to-Market โฆ
Apr 28, 2023ย ยท Rare disease focused Korean biotech Mezzion Pharma has secured nearly $40 million to fund FUEL-2, its confirmatory phase 3 clinical trial, along with future โฆSee details»
Mezzion - Crunchbase Company Profile & Funding
Mezzion is a pharmaceuticals company that develops and discovers medicines. CIO, Executive VP, Information Officer. Non-Management, Executive Engineering, Information Technology. โฆSee details»
Mezzion Pharmaceuticals Announces Dr. Rahul Rathod as the โฆ
Mar 4, 2024ย ยท FORT LEE, N.J. โ Mezzion Pharmaceuticals is a rare disease company conducting the confirmatory pivotal phase 3 clinical trial in Fontan subjects: The Fontan โฆSee details»
Leadership - Mezzion
John Presser is the Chief Business Officer at Mezzion Pharma Co. Ltd. leading business development, commercial and external engagements. John has over 20 years of executive โฆSee details»
Mezzion Pharma - Crunchbase Company Profile & Funding
Mezzion Pharma Co. Ltd is a pharmaceuticals company. Where is Mezzion Pharma's headquarters? Mezzion Pharma is located in Seoul, Seoul-t'ukpyolsi, South Korea. Who โฆSee details»
๋ฉ์ง์จ - ์ํค๋ฐฑ๊ณผ, ์ฐ๋ฆฌ ๋ชจ๋์ ๋ฐฑ๊ณผ์ฌ์
(์ฃผ) ๋ฉ์ง์จ (Mezzion)์ ๋ํ๋ฏผ๊ตญ์ ํฌ๊ท์์ฝํ ์ ์ฝ ๊ฐ๋ฐ ๊ธฐ์ ์ด๋ค [1] ์ ์ฝ ํ๋ณด ๋ฌผ์ง์ ๋์ ํ ๊ฐ๋ฐ์ ์ ๋ฌธ์ผ๋ก ํ๋ ๊ธฐ์ ์ด๋ค [2]See details»
Mezzion Pharma Raises Nearly $40M to Advance a First-to-Market ...
Apr 25, 2023ย ยท Mezzion is looking to bring to market JURVIGO ยฎ (udenafil), a highly selective, unique and potent phosphodiesterase type 5 inhibitor (โPDE-5 inhibitorโ), for specific use in the โฆSee details»
Mezzion Company Profile 2024: Stock Performance & Earnings
Information on stock, financials, earnings, subsidiaries, investors, and executives for Mezzion. Use the PitchBook Platform to explore the full profile.See details»
News - Mezzion
Mezzion Pharma Receives Clear FDA Path Forward for the Approval of Udenafil for Single Ventricle Heart DiseaseSee details»
Notice | ๋ฉ์ง์จ - Mezzion
Nov 4, 2024ย ยท ํ์ฌ, ์ ๋ฝ SME ์ง์ ์ ์ฒญ์ ์๋ฃ ๋์์ผ๋ฉฐ, SA ์ ์ฒญ์ ์ํ ๋ธ๋ฆฌํ ์๋ฃ๋ฅผ ์์ฑํ์ฌ ์ ์ถ, ํด๋น ๊ธฐ๊ด์์ ๊ฒํ ์ค์ ์์ต๋๋ค. ์์ธ๋ฌ ์ ๋ฝ ์์ฝํ์ฒญ (EMA, ๋ฏธ๊ตญ FDA์ โฆSee details»
Investors & News โ Mezzion
Feb 20, 2023ย ยท Mezzion Pharma Raises Nearly $40M to Advance a First-to-Market Treatment Option for Fontan PatientsSee details»
Mezzion Pharma Announces Positive Data Presented to FDA in โฆ
Dec 21, 2021ย ยท Mezzion Pharma Co., Ltd. is headquartered in Korea. Mezzion and its wholly owned subsidiary, Mezzion Pharmaceuticals, Inc., have administrative offices in Deerfield, โฆSee details»
Contact Us - Mezzion
Please feel free to reach out to Mezzion including with inquiries about our udenafil clinical program.See details»